IP Library Granted Patent US 8,420,387
Granted Patent B2
US 8,420,387 · App. 12/590,444 · Granted Apr 16, 2013

Intein-modified enzymes, their production and industrial applications

Inventors: Binzhang Shen (Belmont, MA); Gabor Lazar (Belmont, MA); Humberto de la Vega (Peabody, MA); James Apgar (Somerville, MA); Philip Lessard (Framingham, MA); R. Michael Raab (Arlington, MA)
Assignee: Agrivida, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,420,387
App. No.
12/590,444
Granted
Apr 16, 2013
Kind
B2
Abstract

A method of predicting an intein insertion site in a protein that will lead to a switching phenotype is provided. The method includes identifying a plurality of C/T/S sites within the protein; selecting from the plurality of C/T/S/ sites those that are ranked 0.75 or higher by a support vector machine, within ten angstroms of the active site of the protein, and at or near a loop-β-sheet junction or a loop-α-helix junction. A method of controlling protein activity and hosts including proteins with controlled activity are also provided. Also, intein modified proteins and plants containing intein modified proteins are provided.

Claims (9)

1. A method of making an intein modified protein including:

identifying a plurality of cysteine, serine or threonine sites within the protein, whether native or introduced;

analyzing the local sequence of each cysteine, serine or threonine site in the plurality of cysteine, serine or threonine sites with a support vector machine;

identifying an active site of the protein, wherein a respective distance separates the active site and each of the cysteine, serine or threonine sites in the plurality of cysteine, serine or threonine sites, and identifying the respective distance between the active site and each of the cysteine, serine or threonine sites in the plurality of cysteine, serine or threonine sites; and

identifying a secondary structure of the protein at each of the cysteine, serine or threonine sites in the plurality of cysteine, serine or threonine sites;

inserting an intein into the protein at a site immediately before one of the cysteine, serine or threonine sites in the plurality of cysteine, serine or threonine sites that is ranked 0.75 or higher by the support vector machine, within ten angstroms of the active site, and within ten amino acids from a loop-β-sheet junction or within ten amino acids from a loop-α-helix junction; and

screening the intein modified protein to determine if the intein modified protein has a permissive or switching phenotype.

2. The method of claim 1 further comprising selecting the intein modified protein if it has a switching phenotype and switching is inducible upon exposure to an induction condition.

3. The method of claim 2 , wherein the induction condition is the intein modified protein having an induction temperature of 50° C. or greater.

Assignments (4)
MERGER Recorded Nov 9, 2023
From: AGRIVIDA MERGER SUB, INC.; AGRIVIDA, INC.
To: AGRIVIDA INC.
Reel/Frame 065513/0941 →
SECURITY AGREEMENT Recorded May 7, 2013
From: AGRIVIDA INC.
To: TRIPLEPOINT CAPITAL LLC
Reel/Frame 030370/0134 →
SECURITY AGREEMENT Recorded Dec 6, 2011
From: AGRIVIDA INC.
To: TRIPLEPOINT CAPITAL LLC
Reel/Frame 027334/0572 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 24, 2010
From: SHEN, BINZHANG; LAZAR, GABOR; DE LA VEGA, HUMBERTO; APGAR, JAMES; LESSARD, PHILIP; RAAB, R. MICHAEL
To: AGRIVIDA, INC.
Reel/Frame 024131/0211 →
Continuity (1)
Related Publication 20110111442A1 · May 12, 2011